Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 1712533)

Published in Am J Hum Genet on March 01, 1997

Authors

M Young1, H Inaba, L W Hoyer, M Higuchi, H H Kazazian, S E Antonarakis

Author Affiliations

1: Department of Genetics and Microbiology, University of Geneva, Switzerland.

Articles cited by this

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15

Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science (1985) 5.90

Characterization of the human factor VIII gene. Nature (1984) 5.37

The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J Biol Chem (1986) 4.25

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet (1993) 4.12

The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci U S A (1990) 3.72

Frameshifting is required for production of the transposase encoded by insertion sequence 1. Proc Natl Acad Sci U S A (1989) 3.18

Ribosomal frameshifting viral RNAs. J Gen Virol (1995) 2.86

Translational frameshifting generates the gamma subunit of DNA polymerase III holoenzyme. Proc Natl Acad Sci U S A (1990) 2.78

Translational frameshifting in the control of transposition in bacteria. Mol Microbiol (1993) 2.76

The gamma subunit of DNA polymerase III holoenzyme of Escherichia coli is produced by ribosomal frameshifting. Proc Natl Acad Sci U S A (1990) 2.71

The mutational specificity of DNA polymerases-alpha and -gamma during in vitro DNA synthesis. J Biol Chem (1985) 2.66

An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA. Proc Natl Acad Sci U S A (1992) 2.57

Structural and functional aspects of RNA pseudoknots. Biochemistry (1992) 2.57

Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet (1993) 2.08

Efficient translational frameshifting occurs within a conserved sequence of the overlap between the two genes of a yeast Ty1 transposon. Proc Natl Acad Sci U S A (1988) 1.98

Low activity of -galactosidase in frameshift mutants of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.94

Transcriptional slippage occurs during elongation at runs of adenine or thymine in Escherichia coli. Nucleic Acids Res (1990) 1.87

Pseudo-templated transcription in prokaryotic and eukaryotic organisms. Genes Dev (1991) 1.83

An RNA polymerase mutant with reduced accuracy of chain elongation. Biochemistry (1986) 1.75

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood (1993) 1.53

Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat (1995) 1.53

Immunoradiometric measurement of the factor VIII procoagulant antigen. J Clin Invest (1978) 1.21

Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet (1994) 1.19

Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci U S A (1991) 1.15

Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res (1994) 1.13

Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A (1991) 1.08

Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine). Proc Natl Acad Sci U S A (1989) 1.05

Reading-frame restoration with an apolipoprotein B gene frameshift mutation. Proc Natl Acad Sci U S A (1992) 1.03

Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A. Genomics (1993) 0.90

Partial rescue of human carbonic anhydrase II frameshift mutation by ribosomal frameshift. Proc Natl Acad Sci U S A (1995) 0.85

Articles by these authors

Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat (2000) 13.25

The DNA sequence of human chromosome 21. Nature (2000) 10.66

Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18

Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature (1982) 9.47

High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60

Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature (1987) 8.58

Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21

Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet (1984) 7.97

Nomenclature for the description of human sequence variations. Hum Genet (2001) 7.90

Biology of mammalian L1 retrotransposons. Annu Rev Genet (2001) 6.52

Beta-globin locus is linked to the parathyroid hormone (PTH) locus and lies between the insulin and PTH loci in man. Proc Natl Acad Sci U S A (1983) 6.50

Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (1992) 6.49

Many human L1 elements are capable of retrotransposition. Nat Genet (1997) 6.27

Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01

Reverse transcriptase encoded by a human transposable element. Science (1991) 5.86

Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster. Proc Natl Acad Sci U S A (1982) 5.85

The mutation and polymorphism of the human beta-globin gene and its surrounding DNA. Annu Rev Genet (1984) 5.74

Positional cloning of the APECED gene. Nat Genet (1997) 5.47

A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature (1990) 5.42

Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol (2001) 5.23

Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science (1994) 5.21

Report of the Committee on the Genetic Constitution of Chromosomes 10, 11, and 12. Cytogenet Cell Genet (1985) 5.01

Exon shuffling by L1 retrotransposition. Science (1999) 4.99

Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A (1991) 4.84

Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77

Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest (1973) 4.57

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet (1993) 4.12

Isolation of an active human transposable element. Science (1991) 3.99

OMIM passes the 1,000-disease-gene mark. Nat Genet (2000) 3.92

A mammalian RNA editing enzyme. Nature (1996) 3.90

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet (1995) 3.74

The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci U S A (1990) 3.72

Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. JAMA (1989) 3.65

Single-sperm typing: determination of genetic distance between the G gamma-globin and parathyroid hormone loci by using the polymerase chain reaction and allele-specific oligomers. Proc Natl Acad Sci U S A (1989) 3.50

Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis (1994) 3.12

Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet (1998) 3.00

Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest (1973) 2.94

Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res (2000) 2.84

Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83

Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78

Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP. Nat Cell Biol (2001) 2.75

A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet (1994) 2.68

Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol (1995) 2.66

RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem (1996) 2.64

Improved detection of the sickle mutation by DNA analysis: application to prenatal diagnosis. N Engl J Med (1982) 2.64

Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med (1988) 2.64

RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res Brain Res Rev (1998) 2.62

Transduction of 3'-flanking sequences is common in L1 retrotransposition. Hum Mol Genet (2000) 2.57

The factor VIII complex: structure and function. Blood (1981) 2.50

Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med (1972) 2.49

Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature (1987) 2.49

Deletion of the beta-globin structure gene in hereditary persistence of foetal haemoglobin. Nature (1975) 2.45

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40

Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med (1990) 2.37

Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc Natl Acad Sci U S A (1989) 2.27

Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science (1987) 2.27

Evidence for multiple origins of the beta E-globin gene in Southeast Asia. Proc Natl Acad Sci U S A (1982) 2.24

A novel active L1 retrotransposon subfamily in the mouse. Genome Res (2001) 2.21

Quantification of the close association between DNA haplotypes and specific beta-thalassaemia mutations in Mediterraneans. Nature (1984) 2.18

Laryngeal atresia type III (glottic web) with 22q11.2 microdeletion: report of three patients. Am J Med Genet (1997) 2.17

Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics (1989) 2.16

Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum Mol Genet (1999) 2.15

Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res (2001) 2.14

Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc Natl Acad Sci U S A (1991) 2.10

Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature (1997) 2.09

Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A (1991) 2.09

DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet (1985) 2.09

Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia. N Engl J Med (1983) 2.06

Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J Biol Chem (1996) 2.06

Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet (2001) 2.06

Molecular characterization of seven beta-thalassemia mutations in Asian Indians. EMBO J (1984) 2.04

Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both. Proc Natl Acad Sci U S A (1984) 2.00

An actively retrotransposing, novel subfamily of mouse L1 elements. EMBO J (1998) 1.99

Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature (1982) 1.98

Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet (1998) 1.98

Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci U S A (1997) 1.97

Direct detection of the common Mediterranean beta-thalassemia gene with synthetic DNA probes. An alternative approach for prenatal diagnosis. J Clin Invest (1983) 1.95

Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet (1988) 1.93

beta-Thalassemia in Chinese: use of in vivo RNA analysis and oligonucleotide hybridization in systematic characterization of molecular defects. Proc Natl Acad Sci U S A (1984) 1.92

Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. Proc Natl Acad Sci U S A (1996) 1.92

Hemophilia A. Detection of molecular defects and of carriers by DNA analysis. N Engl J Med (1985) 1.91

Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol Cell Biol (1990) 1.88